We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with Zacks Rank#1 (Strong Buy) and strong growth characteristics for investors to consider today, December 23rd:
Dean Foods Company : This food and beverage company has witnessed the Zacks Consensus Estimate for its current year earnings improving 3.8% over the last 60 days.
Dean Foods has a price/earnings to growth ratio (PEG) of 1.12, compared with 2.53 for the industry. The company possesses a Growth Score of B.
The Chemours Company (CC - Free Report) : This provider of performance chemicals has seen the Zacks Consensus Estimate for its current year earnings soaring 33.7% over the last 60 days.
Chemours has a PEG ratio of 1.16, compared with 1.51 for the industry. The company possesses a Growth Score of A.
Dave & Buster's Entertainment, Inc. (PLAY - Free Report) : This owner and operator of entertainment and dining venues has seen the Zacks Consensus Estimate for its current year earnings improving 6.2% over the last 60 days.
Dave & Buster's Entertainment has a price/earnings to growth ratio (PEG) of 1.57, compared with 1.90 for the industry. The company possesses a Growth Score of B.
Magellan Health, Inc. : This healthcare management company has witnessed the Zacks Consensus Estimate for its current year earnings improving 32.4% over the last 30 days.
You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >>.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Ranked Growth Stocks to Buy for December 23rd
Here are four stocks with Zacks Rank#1 (Strong Buy) and strong growth characteristics for investors to consider today, December 23rd:
Dean Foods Company : This food and beverage company has witnessed the Zacks Consensus Estimate for its current year earnings improving 3.8% over the last 60 days.
DEAN FOODS CO Price and Consensus
DEAN FOODS CO Price and Consensus | DEAN FOODS CO Quote
Dean Foods has a price/earnings to growth ratio (PEG) of 1.12, compared with 2.53 for the industry. The company possesses a Growth Score of B.
The Chemours Company (CC - Free Report) : This provider of performance chemicals has seen the Zacks Consensus Estimate for its current year earnings soaring 33.7% over the last 60 days.
CHEMOURS COMPNY Price and Consensus
CHEMOURS COMPNY Price and Consensus | CHEMOURS COMPNY Quote
Chemours has a PEG ratio of 1.16, compared with 1.51 for the industry. The company possesses a Growth Score of A.
Dave & Buster's Entertainment, Inc. (PLAY - Free Report) : This owner and operator of entertainment and dining venues has seen the Zacks Consensus Estimate for its current year earnings improving 6.2% over the last 60 days.
DAVE&BUSTRS ENT Price and Consensus
DAVE&BUSTRS ENT Price and Consensus | DAVE&BUSTRS ENT Quote
Dave & Buster's Entertainment has a price/earnings to growth ratio (PEG) of 1.57, compared with 1.90 for the industry. The company possesses a Growth Score of B.
Magellan Health, Inc. : This healthcare management company has witnessed the Zacks Consensus Estimate for its current year earnings improving 32.4% over the last 30 days.
MAGELLAN HLTH Price and Consensus
MAGELLAN HLTH Price and Consensus | MAGELLAN HLTH Quote
Magellan Health has a price/earnings to growth ratio (PEG) of 1.14, compared with 1.28 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here
Want to see all of today's Zacks Strong Buys?
You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research. See the stocks free >>.